{"id":"W2589157935","doi":"10.1200/jco.2005.23.16_suppl.5569","title":"A phase I study of VB4–845 in patients with advanced, recurrent head and neck cancer on a weekly dosing scheme","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Viventia Bio (Canada)","funders":"","keywords":"Medicine; Head and neck cancer; Internal medicine; Dosing; Clinical trial; Immunogenicity; Cancer; Phases of clinical research; Oncology; Gastroenterology; Immunology; Antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001237099,0.00121063,0.002486887,0.0006932314,0.0006314637,0.001073972,0.001499344,0.001339292,0.003957704],"category_scores_gemma":[0.0008317117,0.0007467676,0.00156394,0.0006636243,0.001124979,0.0008180295,0.0003670965,0.004242004,0.001031438],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009998793,"about_ca_system_score_gemma":0.001471686,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004062282,"about_ca_topic_score_gemma":0.006866515,"domain_scores_codex":[0.9994372,0.0002057125,0.00001942994,0.00009337941,0.00004208061,0.0002022643],"domain_scores_gemma":[0.9994408,0.0001099196,0.00006421136,0.00006631665,0.000030429,0.0002882494],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6024781,0.1080534,0.008120894,0.0007189054,0.001855083,0.0004011694,0.0007757114,0.006856887,0.08535466,0.0005937014,0.004920045,0.1798716],"study_design_scores_gemma":[0.2853507,0.694747,0.0117371,0.00002361189,0.0004407419,0.0002179828,0.00009608193,0.001455216,0.003487151,0.0001377862,0.002270301,0.00003620256],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9950334,0.001053503,0.0004703376,0.0002961083,0.0001384788,0.0009989114,0.0004207209,0.0001026793,0.00148591],"genre_scores_gemma":[0.9915102,0.001384232,0.001081231,0.0004885039,0.0001781325,0.0009336711,0.001154118,0.00004667749,0.00322331],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004062282,"threshold_uncertainty_score":0.01323986,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1361874555437683,"score_gpt":0.5385583200023969,"score_spread":0.4023708644586286,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}